RHEP · Regional Health Properties, Inc
Market Cap
$4.26M
Shares
3.92M
RHEP metrics
72 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$1.09
Market cap
$4.26M
Price action
19 metricsPrice change (1W)
-6.5%
Price change (30D)
+3.8%
Price change (3M)
-10.3%
Price change (6M)
-22.5%
Price change (YTD)
-15.2%
Price change (1Y)
-45.8%
Trailing year
Price change (5Y)
-90.1%
52-week high
$2.00
52-week low
$1.00
Change from 52-week high
-45.8%
Change from 52-week low
+8.5%
Annualized volatility
78.9%
Beta
0.1
RSI (14D)
51.9
Price vs SMA 50
-0.1%
Price vs SMA 200
-15.6%
Avg volume (3M)
2,434
Relative volume
0.1
Average dollar volume
$2,708
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
3.92M
Valuation
12 metricsP / E (TTM)
0.5
Trailing earnings · reciprocal yield 204.6%
PEG ratio
—
EV / revenue
0.5×
reciprocal yield 193.9%
EV / EBITDA
9.8×
reciprocal yield 10.2%
EV / EBIT
26.7×
reciprocal yield 3.7%
P / sales
0.1×
reciprocal yield 1,914.3%
P / book
—
FCF yield
-92.5%
TTM · current market cap
Buyback yield
1.1%
P / FCF
—
P / operating cash flow
—
Earnings yield
95.6%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.1×
reciprocal yield 47.2%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 47.9%
EV / EBIT historical average (3Y)
163.5×
reciprocal yield 0.6%
EV / EBIT historical average (5Y)
147.5×
reciprocal yield 0.7%
EV / EBITDA historical average (3Y)
27.6×
reciprocal yield 3.6%
EV / EBITDA historical average (5Y)
24.6×
reciprocal yield 4.1%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
86.9%
Operating margin
1.9%
Trailing 12 months
Net margin
5.0%
Gross profit (TTM)
—
Operating profit (TTM)
$1.57M
Net income (TTM)
$4.07M
Trailing 12 months
Diluted EPS (TTM)
$2.22
FCF margin
-4.8%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+143.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$81.52M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+83.3%
Year over year · more shares
Revenue CAGR (3Y)
+14.0%
Revenue CAGR (5Y)
+24.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
6.0%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
$4.31M
Free cash flow (TTM)
−$3.94M
Quick ratio
0.6
Interest coverage
0.6
Net debt / EBITDA
8.8
Return on invested capital
—
Trailing 12 months
Net cash
−$37.79M
Latest balance sheet
Cash & equivalents
$1.70M
Total assets
$67.96M
Total debt
$39.49M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$2.57M
Capital expenditures (TTM)
$1.37M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$355,000
R&D / revenue
—
Stock compensation / revenue
0.4%
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
0.2%
Latest settlement · 6.0 days to cover
Days to cover
6.0d
Short-squeeze score
50 / 100
Insider activity
2 metricsNet insider buying (90D)
−$106
Insider-sentiment score
64 / 100
Risk flags
1 metricsGoing concern
—